There's an outside chance they choose a board member, maybe Singhvi. He's got experience. Especially if there was some internal dust-up. I'd love to be a fly on the wall in that boardroom.
Yep. However, the way one should (IMHO) approach such early stage biotech is trust the science assuming the background information is fully vetted by multiple sources & publications and take a long term position for at least a year or more. I am not a day trader and rather pocket the tax dollars than cut an extra check to Uncle Sam.
News 
Market Data 
Discover 
